Molecular Mechanisms of

Chronic Inflammatory diseases and Cancer

The Reinecker laboratory unravels and targets molecular mechanisms of key human genetic variants that cause chronic inflammatory diseases and cancer by creating novel genetic mouse and human organotypic model systems.

  • Targeting of microtubule based microbial pattern recognition to control disease mechanisms of Inflammatory Bowel Diseases.
  • Controlling innate and adaptive immune responses to microbial pathogens through the Sensor Stimulator of Interferon Genes (STING) pathway.
  • Developing strategies to induce anti-tumor immunity through intracellular dendritic cell activation.
  • Control of adaptive host-defenses by Schlafen family proteins
Hans-Christian Reinecker

Principal Investigator

Hans-Christian Reinecker, M.D.

Dr. Reinecker is internationally recognized as a cell/molecular biologist in the field of innate and adaptive immune responses involved in the pathogenesis of chronic inflammatory diseases and autoimmunity.

Join Our Lab

The Reinecker lab has openings for graduate students and postdocs to join our exciting work.

Explore Opportunities
mountains